%0 Editorial
%T The new life of ibrutinib therapy in CLL: enhancing personalized approaches.
%A Molica S
%A Mauro FR
%J Expert Rev Anticancer Ther
%V 24
%N 9
%D 2024 Sep 15
%M 38993050
%F 3.627
%R 10.1080/14737140.2024.2379921